Mutuleanu MD - Search Results

1

Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Axillary Conversion after Neoadjuvant Chemotherapy-A Single-Tertiary Centre Experience and Review of the Literature.

Lazar AM, Mutuleanu MD, Spiridon PM, Bordea CI, Suta TL, Blidaru A, Gherghe M. Lazar AM, et al. Among authors: mutuleanu md. Diagnostics (Basel). 2023 Sep 20;13(18):3000. doi: 10.3390/diagnostics13183000. Diagnostics (Basel). 2023. PMID: 37761367 Free PMC article.

2

Quantitative vs. Qualitative SPECT-CT Diagnostic Accuracy in Bone Lesion Evaluation-A Review of the Literature.

Mutuleanu MD, Paun DL, Lazar AM, Petroiu C, Trifanescu OG, Anghel RM, Gherghe M. Mutuleanu MD, et al. Diagnostics (Basel). 2023 Sep 17;13(18):2971. doi: 10.3390/diagnostics13182971. Diagnostics (Basel). 2023. PMID: 37761338 Free PMC article. Review.

3

Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis-A New Dimension of Molecular Imaging.

Gherghe M, Lazar AM, Sterea MC, Spiridon PM, Motas N, Gales LN, Coriu D, Badelita SN, Mutuleanu MD. Gherghe M, et al. Among authors: mutuleanu md. J Cardiovasc Dev Dis. 2023 May 31;10(6):242. doi: 10.3390/jcdd10060242. J Cardiovasc Dev Dis. 2023. PMID: 37367407 Free PMC article. Review.

4

Quantitative Assessment of Treatment Response in Metastatic Breast Cancer Patients by SPECT-CT Bone Imaging-Getting Closer to PET-CT.

Gherghe M, Mutuleanu MD, Stanciu AE, Irimescu I, Lazar AM, Toma RV, Trifanescu OG, Anghel RM. Gherghe M, et al. Among authors: mutuleanu md. Cancers (Basel). 2023 Jan 23;15(3):696. doi: 10.3390/cancers15030696. Cancers (Basel). 2023. PMID: 36765651 Free PMC article.

5

Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours.

Gherghe M, Lazar AM, Simion L, Irimescu IN, Sterea MC, Mutuleanu MD, Anghel RM. Gherghe M, et al. Among authors: mutuleanu md. Diagnostics (Basel). 2023 Jan 15;13(2):318. doi: 10.3390/diagnostics13020318. Diagnostics (Basel). 2023. PMID: 36673128 Free PMC article.

6

Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact?

Gherghe M, Lazar AM, Mutuleanu MD, Bordea CI, Ionescu S, Mihaila RI, Petroiu C, Stanciu AE. Gherghe M, et al. Among authors: mutuleanu md. Cancers (Basel). 2022 Dec 29;15(1):207. doi: 10.3390/cancers15010207. Cancers (Basel). 2022. PMID: 36612202 Free PMC article.

7

The New Radiolabeled Peptide ^99mTcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?

Gherghe M, Lazăr AM, Stanciu AE, Mutuleanu MD, Sterea MC, Petroiu C, Galeș LN. Gherghe M, et al. Among authors: mutuleanu md. Cancers (Basel). 2022 May 31;14(11):2725. doi: 10.3390/cancers14112725. Cancers (Basel). 2022. PMID: 35681704 Free PMC article.

8

Radiomics Analysis of [¹⁸F]FDG PET/CT Thyroid Incidentalomas: How Can It Improve Patients' Clinical Management? A Systematic Review from the Literature.

Gherghe M, Lazar AM, Mutuleanu MD, Stanciu AE, Martin S. Gherghe M, et al. Among authors: mutuleanu md. Diagnostics (Basel). 2022 Feb 12;12(2):471. doi: 10.3390/diagnostics12020471. Diagnostics (Basel). 2022. PMID: 35204561 Free PMC article. Review.

9

Quantitative Analysis of SPECT-CT Data in Metastatic Breast Cancer Patients-The Clinical Significance.

Gherghe M, Mutuleanu MD, Stanciu AE, Irimescu I, Lazar A, Bacinschi X, Anghel RM. Gherghe M, et al. Among authors: mutuleanu md. Cancers (Basel). 2022 Jan 6;14(2):273. doi: 10.3390/cancers14020273. Cancers (Basel). 2022. PMID: 35053436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters